BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $257,579 | +4.3% | 8,067 | 0.0% | 0.17% | -3.4% |
| Q1 2023 | $247,012 | -21.7% | 8,067 | 0.0% | 0.18% | -84.0% |
| Q4 2022 | $315,500 | -49.4% | 8,067 | -38.3% | 1.10% | -46.2% |
| Q3 2022 | $623,000 | +23.1% | 13,067 | 0.0% | 2.05% | +65.2% |
| Q2 2022 | $506,000 | -32.4% | 13,067 | 0.0% | 1.24% | -4.0% |
| Q1 2022 | $749,000 | -27.1% | 13,067 | +1.3% | 1.29% | +10.9% |
| Q4 2021 | $1,028,000 | -8.4% | 12,900 | 0.0% | 1.16% | -0.5% |
| Q3 2021 | $1,122,000 | -32.4% | 12,900 | 0.0% | 1.17% | -38.1% |
| Q2 2021 | $1,660,000 | +87.4% | 12,900 | +16.6% | 1.89% | +60.7% |
| Q1 2021 | $886,000 | -0.2% | 11,067 | +1.8% | 1.18% | -3.5% |
| Q4 2020 | $888,000 | +231.3% | 10,875 | 0.0% | 1.22% | +140.4% |
| Q3 2020 | $268,000 | -12.1% | 10,875 | 0.0% | 0.51% | -59.4% |
| Q2 2020 | $305,000 | +10.9% | 10,875 | -28.9% | 1.25% | +1190.7% |
| Q1 2020 | $275,000 | – | 15,300 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |